chevron_leftBack
As of 10 June 2026, Celltrion Pharm, Inc. has a market cap of $1.67B USD, ranking #7894 globally and #207 in South Korea.
It ranks #661 in the Healthcare sector, and #252 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.67BUSD
2.55T KRW
Revenue (TTM)
$180.01MUSD
274.73B KRW
EBITDA (TTM)
$28.03MUSD
42.8B KRW
Net Income (TTM)
$17.05MUSD
26.03B KRW
EBITDA Margin
16%
Profit Margin
9.5%
PE Ratio
98.9
PS Ratio
9.3
PB Ratio
8.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yoo Young-Ho
open_in_new
Employees
328
Founded
1976
Website
celltrionph.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.8% | 0.5% | -1.4% | -22% | -9.5% | 23% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
068760
(주)셀트리온제약
ISIN: KR7068760008
Shares Out.:
Shares Outstanding:
43.54M1
Shares Float:
19.616M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
56,100 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Celltrion Pharm, Inc.
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.11B
445%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.75B
304%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.22B
212%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.95B
196%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.53B
171%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.43B
165%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
45K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
33K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
21K%
|
97.4
|
|
SIX: RO
|
$321.17B
19K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.57B
17K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
16K%
218.9B CHF
|
20.5
|
chevron_leftBack